Furosemide Inhalation in Dyspnea of Mustard Gas-Exposed Patients: A Triple-Blind Randomized Study

REFERENCES

• Adams L., Chronos N., Lane R., Guz A. The measurement of breathlessness induced in normal subjects: Validity in two scaling techniques. Clin. Sci. 1985; 69: 7–16
   PubMed Web of Science ®Google Scholar
• Aghanouri R., Ghanei M., Aslani J., Keivani-Amine H., Rastegar F., Karkhane A. Fibrogenic cytokine levels in bronchoalveolar lavage aspirates 15 years after exposure to SM. Am. J. Physiol. Lung Cell. Mol. Physiol. 2004; 287: 1160–1164
   PubMed Web of Science ®Google Scholar
• Anderson S. D., Wei H. E., Temple D. M. Inhibition by furosemide of inflammatory mediators from lung fragments. N. Engl. J. Med. 1991; 324: 131
   PubMed Web of Science ®Google Scholar
• Barnes P. J. Diuretics and asthma. Thorax 1993; 48: 195–196
   PubMed Web of Science ®Google Scholar
• Beheshti J., Mark E. J., Akbari H. M. H., Aslani J., Ghanei M. Mustard lung secrets: Long term clinicopathologic study following mustard gas exposure. Pathology Res. Pract. 2006; 202: 739–744
   PubMed Web of Science ®Google Scholar
• Bianco S., Pieroni M. G., Refini R. M., Rattoli L., Sestini P. Protective effect of inhaled furosemide on allergen-induced early and late asthmatic reactions. N. Engl. J. Med. 1989; 321: 1069–1073
   PubMed Web of Science ®Google Scholar
• Bianco S., Vaghi A., Robushi M., Pasargiklian M. Prevention of exerciseinduced bronchoconstriction by inhaled furosemide. Lancet 1988; 2: 252–255
   PubMed Web of Science ®Google Scholar
• Brooks S. M. Task group on surveillance for respiratory hazards in the occupational setting. Surveillance for respiratory hazards. ATS News 1982; 8: 12–16
   Google Scholar
• Cavaliere F., Masieri S. Furosemide protective effect against airway obstruction. Curr. Drug Targets 2002; 3: 197–201
   PubMed Web of Science ®Google Scholar
• Chung K. F., Barnes P. J. Loop diuretics and asthma. Pulmon. Pharmacol. 1994; 5: 1–7
   Google Scholar
• Corboz M. R., Ballard S. T., Inglis S. K., Taylor A. E. Dilatory effect of furosemide on rat tracheal arterioles and venules. Am. J. Respir. Crit. Care Med. 1997; 156: 478–483
   PubMed Web of Science ®Google Scholar
• Dompeling E., Jöbsis Q., Vandevijver N. M. A., Wesseling G., Hendriks H. Chronic bronchiolitis in a 5-yr-old child after exposure to sulphur mustard gas. Eur. Respir. J. 2004; 23: 343–346
   PubMed Web of Science ®Google Scholar
• Emad A., Rezaian G. R. The diversity of effects of sulphur mustard gas inhalation on respiratory system 10 years after a single heavy exposure: Analysis of 197 cases. Chest 1997; 112: 734–738
   PubMed Web of Science ®Google Scholar
• Fabbri L., Pauwels R. A., Hard S. S. GOLD scientific committee. Global strategy for the diagnosis, management and prevention of COPD: GOLD executive summary updated 2003. COPD 2004; 1: 105–141
   PubMedGoogle Scholar
• Freed A. N., Taskar V., Schofield B., Omori L. Effect of furosemide on hyperpnea-induced airway obstruction, injury, and microvascular leakage. J. Appl. Physiol. 1996; 81: 2461–2467
   PubMed Web of Science ®Google Scholar
• Ghanei M., Amini Harandi A. Long term consequences from exposure to sulfur mustard: A review. Inhal. Toxicol. 2007; 19: 451–456
   PubMed Web of Science ®Google Scholar
• Ghanei M., Mokhtari M., Mohammad M. M., Aslani J. Bronchiolitis obliterans following exposure to sulfur mustard: Chest high resolution computed tomography. Eur. J. Radiol. 2004; 52: 164–169
   PubMed Web of Science ®Google Scholar
• Ghanei M., Shohrati M., Harandi A. A., Eshraghi M., Aslani J., Alaeddini F., Manzoori H. Inhaled corticosteroids and long-acting beta 2-agonists in treatment of patients with chronic bronchiolitis following exposure to sulfur mustard. Inhal Toxicol. 2007; 19: 889–894
   PubMed Web of Science ®Google Scholar
• Gilbert I. A., Lenner K. A., Nelson J. A., Wolin A. D., Fonke J. M. Inhaled furosemide attenuates hyperpnea-induced obstruction and intra-airway thermal gradients. J. Appl. Physiol. 1994; 76: 409–415
   PubMed Web of Science ®Google Scholar
• Gonzalez-Sanchez R., Trujillo-Hernandez B., Huerta M., Vasquez C., Trujillo X. Furosemide plus albuterol compared with albuterol alone in children with acute asthma. Allergy Asthma Proc. 2002; 23: 181–184
   PubMed Web of Science ®Google Scholar
• Hasham F., Kennedy J. D., Jones R. S. Actions of salbutamol, disodium cromoglycate, and placebo administered as aerosols in acute asthma. Arch. Dis. Child. 1981; 56: 722–72
   PubMed Web of Science ®Google Scholar
• Hinckley J. B. Inhaled furosemide in the treatment of acute exacerbations of asthma. Acad. Emerg. Med. 2000; 7: 1167
   PubMedGoogle Scholar
• Karpel J. P., Dworkin F., Hager D., Feliciano S., Shapiro D., Posner L., Luks D. Inhaled furosemide is not effective in acute asthma. Chest 1994; 106: 1396–1400
   PubMed Web of Science ®Google Scholar
• Knox A. J., Ajao P. Effect of frusemide on airway smooth muscle contractility in vitro. Thorax 1990; 45: 856–859
   PubMed Web of Science ®Google Scholar
• Liss H. P., Grant B. J. B. The effect of nasal flow on breathlessness in patients with chronic obstructive pulmonary disease. Am. Rev. Respir. Dis. 1988; 137: 1285–1288
   PubMed Web of Science ®Google Scholar
• Müller N. L., Miller R. R. Diseases of the bronchioles: CT and histopathologic findings. Radiology 1995; 196: 3–12
   PubMed Web of Science ®Google Scholar
• Nishino T., Ide T., Sudo T., Sato J. Inhaled furosemide greatly alleviates the sensation of experimentally induced dyspnea. Am. J. Respir. Crit. Care Med. 2000; 161: 1963–1967
   PubMed Web of Science ®Google Scholar
• Noseda A., Carpiaux J. P., Markstein C., Meyvaert A., Maertelaer V. Disabling dyspnoea in patients with advanced disease: Lack of effect of nebulized morphine. Eur. Respir. J. 1997; 10: 1079–1083
   PubMed Web of Science ®Google Scholar
• Noseda A., Schmerber J., Prigogine T., Yernault J. C. Perceived effect on shortness of breath of an acute inhalation of saline or terbutaline: Variability and sensitivity of a visual analogue scale in patients with asthma or COPD. Eur. Respir. J. 1992; 5: 1043–1053
   PubMed Web of Science ®Google Scholar
• Ong K. C., Kor A. C., Chong W. F., Earnest A., Wang Y. T. Effects of inhaled furosemide on exertional dyspnea in chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 2004; 169: 1028–1033
   PubMed Web of Science ®Google Scholar
• Ono Y., Kondo T., Tanigaki T., Ohta Y. Furosemide given by inhalation ameliorates acute exacerbation of asthma. J. Asthma 1997; 34: 283–289
   PubMed Web of Science ®Google Scholar
• Pendino J. C., Nannini L. J., Chapman K. R., Slutsky A., Molfino N. A. Effect of inhaled furosemide in acute asthma. J. Asthma 1998; 35: 89–93
   PubMed Web of Science ®Google Scholar
• Robuschi M., Gambaro G., Spagnotto S., Vaghi A., Bianco S. Inhaled furosemide is highly effective in preventing ultrasonically nebulised water bronchoconstriction. Pulmon. Pharmacol. 1987; 1: 187–191
   Google Scholar
• Rodriguez Vazquez J. C., Pino Alfonso P. P., Gassiot Nuno C., Paez Prats I., Fernandez Manzano E. Assessment of the bronchodilator effect of inhaled furosemide compared to salbutamol in asthmatic patients. J. Invest. Allergol. Clin. Immunol. 1998; 8: 115–118
   PubMed Web of Science ®Google Scholar
• Schwartzstein R. M., Lahive K., Pope A., Weinberger S. E., Weiss J. W. Cold facial stimulation reduces breathlessness induced in normal subjects. Am. Rev. Respir. Dis. 1987; 136: 58–61
   PubMed Web of Science ®Google Scholar
• Solway J., Leff A. R. Sensory neuropeptides and airway function. J. Appl. Physiol. 1991; 71: 2077–2087
   PubMed Web of Science ®Google Scholar
• Tanigaki T., Kondo T., Hayashi Y., Katoh H., Kamio K., Urano T., Ohta Y. Rapid response to inhaled frusemide in severe acute asthma with hypercapnia. Respiration 1997; 64: 108–110
   PubMed Web of Science ®Google Scholar
• Thomason J. W., Rice T. W., Milstone A. P. Bronchiolitis obliterans in a survivor of a chemical weapons attack. J. Am. Med. Assoc. 2003; 290: 598–599
   PubMed Web of Science ®Google Scholar
• Van Bever H. P., Desager K. N., Pauwels J. H., Wojciechowski M., Vermeire P. A. Aerosolized furosemide in wheezy infants: A negative report. Pediatr. Pulmonol 1995; 20: 16–20
   PubMed Web of Science ®Google Scholar
• Ventresca P. G., Nichol G. M., Barnes P. J., Chung K. F. Inhaled furosemide inhibits cough induced by low-chloride solutions but not by capsaicin. Am. Rev. Respir. Dis. 1990; 142: 143–146
   PubMed Web of Science ®Google Scholar
• Zoorob R. J., Campbell J. S. Acute dyspnea in the office. Am. Family Physician 2003; 68: 1803–1810
   PubMed Web of Science ®Google Scholar